Friday, 21 May 2010 18:22

Darvon/Darvocet/Propoxyphene

Written by Law Offices Of Gary Green

In 2009, an outside advisory panel to the FDA recommended that Darvon and Darvocet be pulled from the market. Their review indicated that the potential side effects outweighed any benefits of these drugs. More specifically, they found that Darvon and Darvocet can cause serious and potentially fatal heart rhythm abnormalities. The FDA is not required to follow the recommendations of the panel, and both Darvon and Darvocet remained on the market.

In 2010, after electrocardiography data from a clinical study revealed QT interval abnormalities occurred in healthy individuals taking the prescribed dosage of the drug, the FDA removed Darvon and Darvocet from the market.

The QT interval is defined as the measure of time between the start of the Q wave and the end of the T wave in the heart’s electrical cycle.

If you have suffered fatal heart rhythm abnormalities after taking one of these drugs, please contact us at ggreen@gGreen.com.